Ramia de Cap M, Wu LP, Pihan GA, Narayanan D, Morgan EA, Pinkus GS, Cin PD, Hurwitz SN, Bagg A, Patel SS, Tam W, Ouseph MM, Gagan J, Madanat YF, Siddon A, Raess PW, Rogers HJ, Bueso-Ramos CE, Kanagal-Shamanna R, Kurzer JH, Arber DA, Hasserjian RP, Weinberg OK. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leuk Res. 2022 Dec; 123:106965.